Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1Phase 1/2 1

Status

Completed 5Unknown 3Recruiting 3Terminated 2Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 173Leukemia, Myeloid, Acute 153Neoplasm Metastasis 146Breast Neoplasms 143Neoplasms 142Colorectal Neoplasms 135Recurrence 104Ovarian Neoplasms 100Pancreatic Neoplasms 81Lung Neoplasms 81Multiple Myeloma 80Advanced Solid Tumor 80Advanced Solid Tumors 74Prostatic Neoplasms 73Stomach Neoplasms 72Squamous Cell Carcinoma of Head and Neck 72Carcinoma, Hepatocellular 67Glioblastoma 65Melanoma 64Lymphoma, Non-Hodgkin 63Triple Negative Breast Neoplasms 57Myelodysplastic Syndromes 54Lymphoma, B-Cell 53Endometrial Neoplasms 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Glioma 51Lymphoma 49Brain Neoplasms 46Hematologic Neoplasms 44Carcinoma, Renal Cell 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × Advanced Tumors × Clear all
NCT06245122 2026-04-06

A Study of CS23546 in Subjects With Advanced Tumors

Chipscreen Biosciences, Ltd.

Phase 1 Recruiting
156 enrolled

Advanced Tumors

NCT07205198 2026-01-08

A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

Shanghai Institute Of Biological Products

Phase 1 Recruiting
160 enrolled

Advanced Tumors

NCT07179081 2025-09-17

A Study of AL58805 in Patients With Advanced Tumors

Advenchen Laboratories, LLC

Phase 1 Recruiting
40 enrolled

Advanced Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡